Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
about
Interactions of metals and Apolipoprotein E in Alzheimer's diseaseGalactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's diseaseAlzheimer mechanisms and therapeutic strategiesGene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brainLysosomal sorting of amyloid-β by the SORLA receptor is impaired by a familial Alzheimer's disease mutationHuman APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer modelGenome-environment interactions that modulate aging: powerful targets for drug discoverySynapses and Alzheimer's diseaseThe Rationale for Insulin Therapy in Alzheimer's DiseaseApolipoprotein E: from cardiovascular disease to neurodegenerative disordersGenes associated with Alzheimer's disease: an overview and current statusThe amyloid hypothesis of Alzheimer's disease at 25 yearsEmerging Link between Alzheimer's Disease and Homeostatic Synaptic PlasticityTau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesThe past and the future of Alzheimer's disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular eventsImpaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1Dementia of the eye: the role of amyloid beta in retinal degenerationPathogenic protein seeding in Alzheimer disease and other neurodegenerative disordersApolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer diseaseCommon defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploringAlzheimer's disease pathologic cascades: who comes first, what drives whatInconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's diseaseCerebrovascular effects of apolipoprotein E: implications for Alzheimer diseaseDysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseasesUshering in the study and treatment of preclinical Alzheimer diseaseCerebrospinal Fluid Particles in Alzheimer Disease and Parkinson DiseaseThe liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein EDisruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 alleleThe dendritic hypothesis for Alzheimer's disease pathophysiology.Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder ResearchIs ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?Genetic variants associated with neurodegenerative Alzheimer disease in natural modelsACAT1/SOAT1 as a therapeutic target for Alzheimer's diseaseThree dimensions of the amyloid hypothesis: time, space and 'wingmen'Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectivesAnalyzing dendritic spine pathology in Alzheimer's disease: problems and opportunitiesCerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's diseaseApolipoprotein E and Alzheimer disease: risk, mechanisms and therapyOrexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer's disease-risk genesBuying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease
P2860
Q21131068-00EA4028-7861-4FF8-9AF1-58365769AB86Q21133775-92DB096B-D728-42EB-A68F-E59604DDDD0DQ22252311-E12E21DD-7DB0-4EA2-87DF-EF5E0D62DFE8Q24308258-41102453-EAE1-4153-A510-FBB700293738Q24337087-A4AEF3A4-D094-4CB7-8EB5-A0337222333AQ24338827-76585FB5-09E3-4492-ABA3-77532A0639F2Q24615803-5FA1132B-B5D8-4D2B-9EDB-F15C69A53BA7Q26269868-DBB0D00A-64B0-4BEF-B364-5ECADEC33628Q26744834-8B535915-3B71-4686-8903-1E4ACC070F35Q26747482-653ABCED-718C-4F56-BD9C-5FD8A4E22E21Q26747803-C31EA66B-280E-4021-B374-948739DFE007Q26749528-12F7C846-E672-45F0-AF9F-0DE96A162AEEQ26750576-27F6F3FB-447F-4847-9227-83F13D21FEF3Q26769957-10C6EF78-DE16-415F-9748-0730A75CE6E0Q26781635-F7C2EF39-7A91-4227-A0DC-DDCAFED5EBE2Q26800063-40557C7C-6490-4CD7-8393-8C5544709BD4Q26828978-7E960974-8B48-4E70-97E6-32DE80527944Q26850298-EA4762D5-8892-456E-AE66-C78D787A2903Q26858870-211C04EB-B4C7-40FA-AE00-C34DBB63344CQ26861082-E2440AB6-6DE2-4421-BB61-0B196CCECD81Q26995896-1049C772-E352-4DD8-B74D-1FA95E7DEB57Q27003841-AFC02C28-DB39-4F89-957B-35BF6809DB9AQ27008456-EB4623AC-36F9-491A-AE12-24E1B54D7B66Q27009984-47E70DCE-FA6A-4AF8-BBD0-5466208346F6Q27014791-09A20F40-1828-4E81-9510-8255F217F9B7Q27314618-45EE42DB-2C59-41AB-B472-EA039F815299Q27321301-82A98284-D4E9-43DE-8CD1-5965D66E2F6CQ27331411-EBDB93AF-957F-4CBE-BB85-818D5969E63BQ27687404-DE221E8A-9733-4B31-B94F-53EC5DB798C8Q28068029-5A534379-5147-4FC3-BBC5-2D4E4B955299Q28069073-99D30D2D-8D29-4133-AFCB-56030D2D4A13Q28079843-E77DD080-EB64-47C5-A72D-5770F00DA592Q28081654-C1CA32BA-1F5C-4481-B9AB-926092759CB6Q28082768-BEA8B295-4E47-4703-AEA4-302BD190BC9EQ28085612-93D422DF-5AC9-4202-8B38-6F04214DA7E3Q28087158-12FE316D-7880-420D-8B6A-9982DF07EEE6Q28087176-7100CB17-4C5B-4C2A-A0D0-A22E41633CEAQ28282855-0ECBB26D-F34F-45B9-8D5D-18ABFCAFC698Q28315261-CF219E65-532C-426F-8D2D-E3C6FFEC94D6Q28383805-2A9F3611-2961-4044-B0C1-14E38E965352
P2860
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
@ast
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
@en
type
label
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
@ast
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
@en
altLabel
Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
@en
prefLabel
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
@ast
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
@en
P2093
P2860
P50
P1476
Human apoE isoforms differentially regulate brain amyloid-β peptide clearance
@en
P2093
Bruce W Patterson
Floy R Stewart
Hong Jiang
Kelly R Bales
Kwasi G Mawuenyega
Ronald B DeMattos
Steven M Paul
P2860
P304
P356
10.1126/SCITRANSLMED.3002156
P407
P50
P577
2011-06-01T00:00:00Z